IL-1β production increases when microbial components and oxidised LDLs stimulate host immuno-inflammatory and connective tissue cells, with IL-1β recognized as major modulator of osteoclastogenesis, a primary cause of periodontal tissue damage and endothelial cell dysfunction during CHD [10, 32, 52]. Here, IL1B is linked to coronary artery disorder.